Bristol-Myers To Purchase Medarex For $2.1B

By Morgan Bettex · July 23, 2009, 4:22 PM EDT

In an effort to secure a top position in the biologics industry, Bristol-Myers Squibb Co. has agreed to buy Medarex Inc., which develops human antibody-based therapeutics to treat life-threatening diseases, in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Morgan

July 30, 2009
Pfizer Finalizes $75M Trovan Deal With Nigeria
July 24, 2009
Partners Healthcare To Pay $2.7M In Back Wages
July 20, 2009
Investors Sue Caraco Over Plant Inspections, Raids
July 16, 2009
Mannatech Sues Rivals Over Diet Supplement Patents
July 14, 2009
Dosage Issue Spurs Recall Of Acetaminophen Drops
July 02, 2009
SF Health Plan Seeks Class Cert. In McKesson AWP Suit
June 29, 2009
Daiichi Sankyo Attacks Apotex Over Evoxac ANDA
June 26, 2009
FDA Blasts Medtronic Over Slow Drug Pump Recall
June 09, 2009
NAACP Seeks Class Cert. In Lilly Race Bias Suit
May 29, 2009
FTC, Wholesalers Amend AndroGel Complaints